GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » Book Value per Share

Eris Lifesciences (NSE:ERIS) Book Value per Share : ₹190.12 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Book Value per Share?

Eris Lifesciences's book value per share for the quarter that ended in Mar. 2024 was ₹190.12.

During the past 12 months, Eris Lifesciences's average Book Value Per Share Growth Rate was 17.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 17.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 31.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Eris Lifesciences was 53.10% per year. The lowest was 17.90% per year. And the median was 32.30% per year.

Eris Lifesciences's current price is ₹916.10. Its book value per share for the quarter that ended in Mar. 2024 was ₹190.12. Hence, today's PB Ratio of Eris Lifesciences is 4.82.

During the past 12 years, the highest P/B Ratio of Eris Lifesciences was 14.89. The lowest was 3.54. And the median was 5.14.


Eris Lifesciences Book Value per Share Historical Data

The historical data trend for Eris Lifesciences's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Book Value per Share Chart

Eris Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.47 116.10 140.39 161.48 190.12

Eris Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.48 - 177.29 - 190.12

Competitive Comparison of Eris Lifesciences's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eris Lifesciences's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's PB Ratio falls into.



Eris Lifesciences Book Value per Share Calculation

Eris Lifesciences's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(25,861-0)/136
=190.12

Eris Lifesciences's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(25,861-0)/136
=190.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Eris Lifesciences  (NSE:ERIS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Eris Lifesciences Book Value per Share Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eris Lifesciences (NSE:ERIS) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (NSE:ERIS) Headlines

No Headlines